Search results
16 Jun 2023 · Chronic myelogenous leukemia also can be called chronic myeloid leukemia and chronic granulocytic leukemia. It typically affects older adults and rarely occurs in children, though it can occur at any age.
Chronic myeloid leukemia (CML) is a slow-growing cancer that affects the blood-forming cells of the bone marrow. It is caused by a genetic change that forms an abnormal gene called BCR-ABL, and it can be treated with targeted therapy or stem cell transplant.
Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a cancer of the white blood cells. It is a form of leukemia characterized by the increased and unregulated growth of myeloid cells in the bone marrow and the accumulation of these cells in the blood.
14 Feb 2023 · Learn about CML, a blood cancer that starts in the bone marrow and affects white blood cells. Find out how it's diagnosed, treated and prevented, and what complications it may cause.
16 Jun 2023 · The medicines are called tyrosine kinase inhibitors, also known as TKIs. TKIs are the initial treatment for people diagnosed with chronic myelogenous leukemia. Side effects of these targeted medicines include swelling or puffiness of the skin, nausea, muscle cramps, fatigue, diarrhea, and skin rashes.
Learn about the pathophysiology, symptoms, diagnosis, and treatment of CML, a myeloproliferative neoplasm caused by the Ph chromosome. Find out the prognosis, key points, and more information on this hematologic malignancy.
Learn about CML, a type of leukemia that starts in the bone marrow and invades the blood. Find out about causes, risk factors, diagnosis, treatment, and survivorship.
